Anti-HER2 immunoliposomes for targeted drug delivery

Annals of the New York Academy of Sciences

Volumn 886, Issue , 1999, Pages 293-296

  Hong, K ^a,c   Kirpotin, D B ^a   Park, J W ^b   Shao, Y ^a   Shalaby, R ^a   Colbern, G ^a   Benz, C C ^b   Papahadjopoulos, D ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; IMMUNOLIPOSOME; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE NEU; TUMOR XENOGRAFT;

ANIMALIA;

EID: 0033452416     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09440.x     Document Type: Conference Paper

References (8)

1. 1. Allen, T.M. & A. Chonn. 1987. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 223: 42-46.
2. 2. Papahadjopoulos, D., T.M. Allen, A. Gabizon, E. Mayhew, K. Matthay. S.-K. Huang, K-D. Lee, M.C. Woodle, D.D. Lasic, C. Redemann & F.J. Martin. 1991. Sterically stabilized liposomes: Improvements in pharmacokinetics and anti-tumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA 88: 11460-11464.
3. 3. Olson, F., C.A. Hunt, F.C. Szoka, W.J. Vail & D. Papahadjopoulos. 1979. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim. Biophys. Acta 557: 9š23.
4. 4. Haran, G., R. Cohen, L.K. Bar & Y. Barenholz. 1993. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim. Biophys. Acta 1149: 180-184.
5. 5. Sznol, M. & J. Holmlund. 1997. Antigen-specific agents in development. Semin. Oncol. 24: 173-186.
6. 6. Slamon, D.J., G.M. Clark, S.G. Wong, W.J. Levin, A. Ullrich & W.L. McGuire. 1987. Human breast cancer: Correlation of relapse and survival with amplification of HER2/neu oncogene. Science 235: 177-182.
7. 7. Park, J.W., K. Hong, P. Carter, H. Asgari, L.Y. Guo, G.A. Keller, C. Wirth, R. Shalaby, C. Kotts, W.I. Wood, D. Papahadjopoulos & C.C. Benz. 1995. Development of anti-p185HER2 immunoliposomes for cancer therapy. Proc. Natl. Acad. Sci. USA 92: 1327-1331.
8. 8. Kirpotin, D., J. W. Park, K. Hong, S. Zalipsky, W.L. Li, P. Carter, C.C. Benz & D. Papahadjopoulos. 1997. Sterically stabilized anti-HER2 immunoliposomes: Design and targeting to human breast cancer cell in vitro. Biochemistry 36: 66-75.